These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
516 related articles for article (PubMed ID: 28821470)
21. Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort. Bernaudin F; Verlhac S; Arnaud C; Kamdem A; Chevret S; Hau I; Coïc L; Leveillé E; Lemarchand E; Lesprit E; Abadie I; Medejel N; Madhi F; Lemerle S; Biscardi S; Bardakdjian J; Galactéros F; Torres M; Kuentz M; Ferry C; Socié G; Reinert P; Delacourt C Blood; 2011 Jan; 117(4):1130-40; quiz 1436. PubMed ID: 21068435 [TBL] [Abstract][Full Text] [Related]
22. Transcranial Doppler changes in children with sickle cell disease on transfusion therapy. Minniti CP; Gidvani VK; Bulas D; Brown WA; Vezina G; Driscoll MC J Pediatr Hematol Oncol; 2004 Oct; 26(10):626-30. PubMed ID: 15454832 [TBL] [Abstract][Full Text] [Related]
23. Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial. Ware RE; Davis BR; Schultz WH; Brown RC; Aygun B; Sarnaik S; Odame I; Fuh B; George A; Owen W; Luchtman-Jones L; Rogers ZR; Hilliard L; Gauger C; Piccone C; Lee MT; Kwiatkowski JL; Jackson S; Miller ST; Roberts C; Heeney MM; Kalfa TA; Nelson S; Imran H; Nottage K; Alvarez O; Rhodes M; Thompson AA; Rothman JA; Helton KJ; Roberts D; Coleman J; Bonner MJ; Kutlar A; Patel N; Wood J; Piller L; Wei P; Luden J; Mortier NA; Stuber SE; Luban NLC; Cohen AR; Pressel S; Adams RJ Lancet; 2016 Feb; 387(10019):661-670. PubMed ID: 26670617 [TBL] [Abstract][Full Text] [Related]
24. Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia. Miller ST; Wright E; Abboud M; Berman B; Files B; Scher CD; Styles L; Adams RJ; J Pediatr; 2001 Dec; 139(6):785-9. PubMed ID: 11743502 [TBL] [Abstract][Full Text] [Related]
25. Magnetic resonance imaging/angiography and transcranial Doppler velocities in sickle cell anemia: results from the SWiTCH trial. Helton KJ; Adams RJ; Kesler KL; Lockhart A; Aygun B; Driscoll C; Heeney MM; Jackson SM; Krishnamurti L; Miller ST; Sarnaik SA; Schultz WH; Ware RE; Blood; 2014 Aug; 124(6):891-8. PubMed ID: 24914136 [TBL] [Abstract][Full Text] [Related]
26. Pain and other non-neurological adverse events in children with sickle cell anemia and previous stroke who received hydroxyurea and phlebotomy or chronic transfusions and chelation: results from the SWiTCH clinical trial. Alvarez O; Yovetich NA; Scott JP; Owen W; Miller ST; Schultz W; Lockhart A; Aygun B; Flanagan J; Bonner M; Mueller BU; Ware RE; Am J Hematol; 2013 Nov; 88(11):932-8. PubMed ID: 23861242 [TBL] [Abstract][Full Text] [Related]
27. [Cerebral vasculopathy in pediatric sickle-cell anemia]. Kossorotoff M; Grevent D; de Montalembert M Arch Pediatr; 2014 Apr; 21(4):404-14. PubMed ID: 24630541 [TBL] [Abstract][Full Text] [Related]
28. Long-term follow-up of pediatric sickle cell disease patients with abnormal high velocities on transcranial Doppler. Bernaudin F; Verlhac S; Coïc L; Lesprit E; Brugières P; Reinert P Pediatr Radiol; 2005 Mar; 35(3):242-8. PubMed ID: 15703901 [TBL] [Abstract][Full Text] [Related]
29. Hydroxycarbamide treatment reduces transcranial Doppler velocity in the absence of transfusion support in children with sickle cell anaemia, elevated transcranial Doppler velocity, and cerebral vasculopathy: the EXTEND trial. Rankine-Mullings A; Reid M; Soares D; Taylor-Bryan C; Wisdom-Phipps M; Aldred K; Latham T; Schultz WH; Knight-Madden J; Badaloo A; Lane A; Adams RJ; Ware RE Br J Haematol; 2021 Nov; 195(4):612-620. PubMed ID: 34291449 [TBL] [Abstract][Full Text] [Related]
30. Multicenter prospective study of children with sickle cell disease: radiographic and psychometric correlation. Bernaudin F; Verlhac S; Fréard F; Roudot-Thoraval F; Benkerrou M; Thuret I; Mardini R; Vannier JP; Ploix E; Romero M; Cassé-Perrot C; Helly M; Gillard E; Sebag G; Kchouk H; Pracros JP; Finck B; Dacher JN; Ickowicz V; Raybaud C; Poncet M; Lesprit E; Reinert PH; Brugières P J Child Neurol; 2000 May; 15(5):333-43. PubMed ID: 10830200 [TBL] [Abstract][Full Text] [Related]
31. The other side of abnormal: a case series of low transcranial Doppler velocities associated with stroke in children with sickle cell disease. Buchanan ID; James-Herry A; Osunkwo I J Pediatr Hematol Oncol; 2013 Oct; 35(7):543-6. PubMed ID: 23211694 [TBL] [Abstract][Full Text] [Related]
34. Can peak systolic velocities be used for prediction of stroke in sickle cell anemia? Jones A; Granger S; Brambilla D; Gallagher D; Vichinsky E; Woods G; Berman B; Roach S; Nichols F; Adams RJ Pediatr Radiol; 2005 Jan; 35(1):66-72. PubMed ID: 15517239 [TBL] [Abstract][Full Text] [Related]
35. Children with sickle cell anemia with normal transcranial Doppler ultrasounds and without silent infarcts have a low incidence of new strokes. Jordan LC; Roberts Williams DO; Rodeghier MJ; Covert Greene BV; Ponisio MR; Casella JF; McKinstry RC; Noetzel MJ; Kirkham FJ; Meier ER; Fuh B; McNaull M; Sarnaik S; Majumdar S; McCavit TL; DeBaun MR Am J Hematol; 2018 Jun; 93(6):760-768. PubMed ID: 29520844 [TBL] [Abstract][Full Text] [Related]
36. Stroke With Transfusions Changing to Hydroxyurea (SWiTCH): a phase III randomized clinical trial for treatment of children with sickle cell anemia, stroke, and iron overload. Ware RE; Schultz WH; Yovetich N; Mortier NA; Alvarez O; Hilliard L; Iyer RV; Miller ST; Rogers ZR; Scott JP; Waclawiw M; Helms RW Pediatr Blood Cancer; 2011 Dec; 57(6):1011-7. PubMed ID: 21826782 [TBL] [Abstract][Full Text] [Related]
37. Organ iron accumulation in chronically transfused children with sickle cell anaemia: baseline results from the TWiTCH trial. Wood JC; Cohen AR; Pressel SL; Aygun B; Imran H; Luchtman-Jones L; Thompson AA; Fuh B; Schultz WH; Davis BR; Ware RE; Br J Haematol; 2016 Jan; 172(1):122-30. PubMed ID: 26523836 [TBL] [Abstract][Full Text] [Related]
38. Comparison of transcranial color Doppler imaging (TCDI) and transcranial Doppler (TCD) in children with sickle-cell anemia. Jones AM; Seibert JJ; Nichols FT; Kinder DL; Cox K; Luden J; Carl EM; Brambilla D; Saccente S; Adams RJ Pediatr Radiol; 2001 Jul; 31(7):461-9. PubMed ID: 11486797 [TBL] [Abstract][Full Text] [Related]
39. Hydroxyurea therapy lowers transcranial Doppler flow velocities in children with sickle cell anemia. Zimmerman SA; Schultz WH; Burgett S; Mortier NA; Ware RE Blood; 2007 Aug; 110(3):1043-7. PubMed ID: 17429008 [TBL] [Abstract][Full Text] [Related]
40. Silent infarcts in children with sickle cell anemia and abnormal cerebral artery velocity. Pegelow CH; Wang W; Granger S; Hsu LL; Vichinsky E; Moser FG; Bello J; Zimmerman RA; Adams RJ; Brambilla D; Arch Neurol; 2001 Dec; 58(12):2017-21. PubMed ID: 11735775 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]